Topiramate in pregnancy: Preliminary experience from the uk epilepsy and pregnancy register

Neurology

Volumn 72, Issue 23, 2009, Pages 2054-2055

  Martínez Frías, María Luisa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; TOPIRAMATE; TRICHOSTATIN A; VALPROIC ACID;

DRUG ACETYLATION; ENZYME INHIBITION; EPILEPSY; HUMAN; LETTER; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; SIDE EFFECT; TERATOGENESIS; TERATOGENICITY; UNITED KINGDOM;

EID: 67649491199     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000349659.03687.a7     Document Type: Letter

References (5)

1. S Hunt A Russell WH Smithson Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register Neurology 71 2008 272 276
2. S Eyal B Yagen E Sobol Y Altschuler M Shmuel M Bialer The activity of antiepileptic drugs as histone deacetylase inhibitors Epilepsia 45 2004 737 744
3. N Gurvich MG Berman BS Wittner RC Gentleman PS Klein JB Green Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo FASEB J 19 2005 1166 1168
4. E Menegola F Di Renzo ML Broccia E Giavini Inhibition of histone deacetylase as a new mechanism of teratogenesis Birth Defects Res C Embryo Today 78 2006 345 353
5. A Ornoy N Zvi J Arnon R Wajnberg S Shechtman O Diav-Citrin The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies Reprod Toxicol 25 2008 388 389